252 related articles for article (PubMed ID: 9594163)
1. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
Zhang H; Zhao Z; Sun H
Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.
Allard P; Fradet Y; Têtu B; Bernard P
Clin Cancer Res; 1995 Oct; 1(10):1195-202. PubMed ID: 9815912
[TBL] [Abstract][Full Text] [Related]
3. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
4. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens.
Sagerman PM; Saigo PE; Sheinfeld J; Charitonowics E; Cordon-Cardo C
Acta Cytol; 1994; 38(4):517-23. PubMed ID: 7913791
[TBL] [Abstract][Full Text] [Related]
5. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.
Cordon-Cardo C; Wartinger DD; Melamed MR; Fair W; Fradet Y
Am J Pathol; 1992 Feb; 140(2):375-85. PubMed ID: 1739131
[TBL] [Abstract][Full Text] [Related]
6. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder.
Lee E; Schwaibold H; Fradet Y; Huland E; Huland H
J Urol; 1997 Mar; 157(3):1070-3. PubMed ID: 9072545
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues.
Ben-Aïssa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Braesch-Andersen S; Lagerkvist M; Lundblad ML; Gustafson H; Perlmann P
Anticancer Res; 1986; 6(2):165-70. PubMed ID: 2423013
[TBL] [Abstract][Full Text] [Related]
9. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
10. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
11. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
Huland E; Arndt R; Huland H
Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
[TBL] [Abstract][Full Text] [Related]
13. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
Masuko T; Abe J; Yagita H; Hashimoto Y
Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
[TBL] [Abstract][Full Text] [Related]
14. Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211.
Bergeron A; LaRue H; Fradet Y
Cancer Res; 1996 Feb; 56(4):908-15. PubMed ID: 8631032
[TBL] [Abstract][Full Text] [Related]
15. Translational studies of glutathione in bladder cancer cell lines and human specimens.
Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
17. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.
Kurashige T; Noguchi Y; Saika T; Ono T; Nagata Y; Jungbluth A; Ritter G; Chen YT; Stockert E; Tsushima T; Kumon H; Old LJ; Nakayama E
Cancer Res; 2001 Jun; 61(12):4671-4. PubMed ID: 11406534
[TBL] [Abstract][Full Text] [Related]
18. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
Wada T; Shimabukuro T; Kurisu H; Shameem IA; Yoshihiro S; Matsuyama H; Naito K; Hashimoto O; Tanaka K
Hinyokika Kiyo; 1993 Apr; 39(4):313-9. PubMed ID: 8099249
[TBL] [Abstract][Full Text] [Related]
19. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HER-2/neu oncogene and transitional cell carcinoma of bladder.
Jalali Nadoushan MR; Taheri T; Jouian N; Zaeri F
Urol J; 2007; 4(3):151-4. PubMed ID: 17987577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
